GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-06-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-0705PMID 20534737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• The TGF-β Superfamily Cytokine MIC-1/GDF15: Secretory Mechanisms Facilitate Creation of Latent Stromal Stores

  2010cited by this paper
• Progressive Postnatal Motoneuron Loss in Mice Lacking GDF-15

  2009cited by this paper
• Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity.

  2009cited by this paper
• Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.

  2009cited by this paper
• Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

  2009influential reference
• Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines.

  2008cited by this paper
• Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

  2008cited by this paper
• Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR

  2008cited by this paper
• Regulatory T cells and treatment of cancer.

  2008cited by this paper
• Tumor-Specific Efficacy of Transforming Growth Factor-βRI Inhibition in Eker Rats

  2007cited by this paper
• Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15

  2007cited by this paper
• Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1

  2007cited by this paper
• Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.

  2007cited by this paper
• Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Distinct role of macrophages in different tumor microenvironments.

  2006cited by this paper
• Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9

  2006cited by this paper
• Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia.

  2006cited by this paper
• The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.

  2005cited by this paper
• Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

  2005cited by this paper
• HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.

  2005cited by this paper
• PL74, a novel member of the transforming growth factor-beta superfamily, is overexpressed in preeclampsia and causes apoptosis in trophoblast cells.

  2005cited by this paper
• The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide

  2005cited by this paper
• Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

  2005cited by this paper
• RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo

  2004cited by this paper
• Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage.

  2004cited by this paper
• MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

  2003cited by this paper
• CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

  2003cited by this paper
• Induction of MIC-1/growth differentiation factor-15 following bile duct injury

  2003cited by this paper
• MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

  2003cited by this paper
• Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.

  2003cited by this paper
• Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

  2003cited by this paper
• A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape1

  2002cited by this paper
• Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1

  2002cited by this paper
• Molecular Cloning and Characterization of Human Nonsteroidal Anti-inflammatory Drug-activated Gene Promoter

  2001cited by this paper
• Molecular Cloning and Characterization of Human Nonsteroidal Anti-inflammatory Drug-activated Gene Promoter BASAL TRANSCRIPTION IS MEDIATED BY Sp1 AND Sp3*

  2001cited by this paper
• GDF-15/MIC-1 a novel member of the TGF-beta superfamily.

  2000cited by this paper
• Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression*

  2000cited by this paper
• Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues

  1999cited by this paper
• Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses

  1998cited by this paper
• Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family*

  1998influential reference
• Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta.

  1997cited by this paper
• MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

  1997cited by this paper
• PLAB, a novel placental bone morphogenetic protein.

  1997cited by this paper
• The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.

  1995cited by this paper
• Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.

  1995cited by this paper
• Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

  1978cited by this paper

• GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance.

  2026cites this paper
• Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study

  2025cites this paper
• Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment

  2025cites this paper
• Inhibition of GDF15/GFRAL: A novel opportunity for the treatment of solid tumors.

  2025cites this paper
• 6-Gingerol enhances the anti-tumor activity of temozolomide by inhibiting EGR1/GDF15 signaling in glioblastoma

  2025cites this paper
• Systems analysis uncovers early temozolomide responses and peptide antigens in glioblastoma

  2025cites this paper
• New Horizons with Growth Differentiation Factor 15 in Oncology: From Cancer Cachexia and Tumour Immunity to Novel Therapeutic Strategies

  2025cites this paper
• The glioma microenvironment and its impact on antitumor immunity

  2025cites this paper
• The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy

  2025cites this paper
• Functional characteristics of fresh antitumor immune interferer GDF-15 in multiple cancers

  2025cites this paper
• What Is the Potential Relevance of Growth and Differentiation Factor-15 in Neurologic Disease?

  2025cites this paper
• SynProtX: a large-scale proteomics-based deep learning model for predicting synergistic anticancer drug combinations

  2025cites this paper
• GDF15: from biomarker to target in cancer cachexia.

  2025cites this paper
• Identification of a ferroptosis related genes signature and GDF15 contributing to a new perspective for the diagnosis of CRPC

  2025cites this paper
• Desensitizing Effect of Intra‐Tumoral GDF‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer

  2025influential citation
• First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors

  2025cites this paper
• GDF15 drives de novo lipogenesis and contributes to ovarian cancer metastasis.

  2025cites this paper
• Astrocytes: a potential avenue for depression and cancer

  2025cites this paper
• Growth and differentiation factor 15: An emerging therapeutic target for brain diseases.

  2025cites this paper
• Screening activity of brain cancer-derived factors on primary human brain pericytes

  2024cites this paper
• GDF15 promotes corneal neovascularization and RB cell progression via AKT/ERK signal pathway

  2024cites this paper
• GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process

  2024cites this paper
• Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis.

  2024cites this paper
• ZBTB18 regulates cytokine expression and affects microglia/macrophage recruitment and commitment in glioblastoma

  2024cites this paper
• GDF15 is still a mystery hormone.

  2024cites this paper
• Growth differentiation factor 7 alleviates the proliferation and metastasis of hepatocellular carcinoma

  2024cites this paper
• CD151 identifies a NK cell subset that is enriched in COVID-19 patients and correlates with disease severity.

  2024cites this paper
• Interleukin 4 and cancer resistance in glioblastoma multiforme

  2024cites this paper
• The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer

  2024cites this paper
• The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas

  2024influential citation
• The implicated role of GDF15 in gastrointestinal cancer

  2024cites this paper
• GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications

  2024cites this paper
• Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney Disease

  2024cites this paper
• Autophagy in glioblastoma: A mechanistic perspective

  2024cites this paper
• Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma

  2024cites this paper
• The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury.

  2024cites this paper
• GDF-15 Suppresses Puromycin Aminonucleoside-Induced Podocyte Injury by Reducing Endoplasmic Reticulum Stress and Glomerular Inflammation

  2024cites this paper
• Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review

  2024cites this paper
• Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance

  2023cites this paper
• Circulating biomarkers in familial cerebral cavernous malformation

  2023cites this paper
• Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarker

  2023cites this paper
• Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

  2023cites this paper
• ELFN1-AS1 promotes GDF15-mediated immune escape of colorectal cancer from NK cells by facilitating GCN5 and SND1 association

  2023cites this paper
• GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation

  2023cites this paper
• GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex

  2023cites this paper
• Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance

  2022cites this paper
• Growth Differentiation Factor-15 in Immunity and Aging

  2022cites this paper
• Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.

  2022cites this paper
• An active glutamine/α-ketoglutarate/HIF-1α axis prevents pregnancy loss by triggering decidual IGF1+GDF15+NK cell differentiation

  2022cites this paper
• Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance

  2022cites this paper
• Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis

  2022cites this paper
• Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

  2022cites this paper
• Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences

  2022cites this paper
• Growth differentiation factor-15 overexpression promotes cell proliferation and predicts poor prognosis in cerebral lower-grade gliomas correlated with hypoxia and glycolysis signature.

  2022cites this paper
• GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme

  2021cites this paper
• Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.

  2021cites this paper
• GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor

  2021cites this paper
• Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer

  2021cites this paper
• Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

  2021cites this paper
• GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer

  2021cites this paper
• The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

  2021cites this paper
• Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment

  2021cites this paper
• Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma

  2021cites this paper
• Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment.

  2021cites this paper
• Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells

  2021cites this paper
• Mechanism of Ferritin Heavy Chain in the Proliferation and Migration of Prostate Cancer Cells

  2021cites this paper
• Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

  2021cites this paper
• Rediscovering potential molecular targets for glioma therapy through the analysis of the cell of origin, microenvironment, and metabolism.

  2021cites this paper
• Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs

  2021cites this paper
• GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2–c-Fos–LIF signaling

  2021cites this paper
• Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis.

  2020cites this paper
• c‐Fos separation from Lamin A/C by GDF15 promotes colon cancer invasion and metastasis in inflammatory microenvironment

  2020cites this paper
• Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activation

  2020cites this paper
• Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels

  2020cites this paper
• Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles.

  2020cites this paper
• Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure

  2020cites this paper
• Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.

  2020cites this paper
• GDF15: A Hormone Conveying Somatic Distress to the Brain

  2020cites this paper
• Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

  2020cites this paper
• Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player

  2020cites this paper
• HIP1 mediates oncogenic transformation and cancer progression through STAT3 signalling

  2020cites this paper
• GDF15, an update of the physiological and pathological roles it plays: a review

  2020cites this paper
• GDF15 knockdown suppresses cervical cancer cell migration in vitro through the TGF‐β/Smad2/3/Snail1 pathway

  2020cites this paper
• Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches

  2020cites this paper
• Mitochondrial stress and GDF15 in the pathophysiology of sepsis.

  2020cites this paper
• GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates.

  2020cites this paper
• Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness

  2020cites this paper
• GDF15 Promotes Corneal Neovascularization and Retinoblastoma Cell Progression via AKT/ERK Signal Pathway

  2020cites this paper
• GDF15 induced apoptosis and cytotoxicity in A549 cells depends on TGFBR2 expression

  2019cites this paper
• Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma

  2019influential citation
• Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial

  2019cites this paper
• Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.

  2019cites this paper
• Coordinated Expression of Ras Suppressor 1 (RSU-1) and Growth Differentiation Factor 15 (GDF15) Affects Glioma Cell Invasion

  2019cites this paper
• YY1-Activated Long Noncoding RNA SNHG5 Promotes Glioblastoma Cell Proliferation Through p38/MAPK Signaling Pathway

  2019cites this paper
• GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer.

  2019cites this paper
• Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15

  2019cites this paper
• Growth differentiation factor 15 and its role in carcinogenesis: an update

  2019influential citation
• Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

  2019cites this paper
• Cancer as a tissue: The significance of cancer‐stromal interactions in the development, morphogenesis and progression of human upper digestive tract cancer

  2018cites this paper
• Growth differentiation factor 15 ( GDF 15 ) contributes to invasion and anti-anoikis of hepatocellular cancer through TGF-β / Smad-associated signaling

  2018cites this paper